Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus

被引:6
作者
Tan, Ming [1 ]
Jiang, Xi [1 ]
机构
[1] Univ Cincinnati Coll Med, Div Infect Dis, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA
关键词
antigen presentation; bivalent vaccine; calicivirus; influenza virus; M2e epitope; norovirus; P domain; P particle; rotavirus VP8; vaccine platform; BLOOD GROUP ANTIGENS; INTEGRAL MEMBRANE-PROTEIN; INFECTED-CELL SURFACE; COWPEA MOSAIC-VIRUS; NORWALK VIRUS; CAPSID PROTEIN; RECEPTOR-BINDING; HOST INTERACTION; STRUCTURAL BASIS; GII-4; NOROVIRUS;
D O I
10.2217/NNM.12.62
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Noroviruses (NoVs) are important pathogens causing epidemic acute gastroenteritis that affects millions of people worldwide. The protruding (P) domain of the NoV capsid protein, the surface antigen of NoV, forms a 24-mer subviral particle called the P particle that is an excellent candidate vaccine against NoVs. The P particles are easily produced in Escherichia coli, highly stable and highly immunogenic. Each P domain has three surface loops that can be used for foreign antigen presentation, making the P particles a useful platform for vaccine development against other infectious diseases. This article summarizes the discovery, structure, development and applications of the P particles as a vaccine against NoVs, as well as a vaccine platform against rotavirus, influenza virus and possibly other pathogens in the future.
引用
收藏
页码:889 / 897
页数:9
相关论文
共 54 条
[21]   INFLUENZA VIRUS-M2 PROTEIN IS AN INTEGRAL MEMBRANE-PROTEIN EXPRESSED ON THE INFECTED-CELL SURFACE [J].
LAMB, RA ;
ZEBEDEE, SL ;
RICHARDSON, CD .
CELL, 1985, 40 (03) :627-633
[22]   Human susceptibility and resistance to Norwalk virus infection [J].
Lindesmith, L ;
Moe, C ;
Marionneau, S ;
Ruvoen, N ;
Jiang, X ;
Lindbland, L ;
Stewart, P ;
LePendu, J ;
Baric, R .
NATURE MEDICINE, 2003, 9 (05) :548-553
[23]   Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design [J].
Liu, WL ;
Zou, P ;
Ding, J ;
Lu, Y ;
Chen, YH .
MICROBES AND INFECTION, 2005, 7 (02) :171-177
[24]   A viral nanoparticle with dual function as an anthrax antitoxin and vaccine [J].
Manayani, Darly J. ;
Thomas, Diane ;
Dryden, Kelly A. ;
Reddy, Vijay ;
Siladi, Marc E. ;
Marlett, John M. ;
Rainey, G. Jonah A. ;
Pique, Michael E. ;
Scobie, Heather M. ;
Yeager, Mark ;
Young, John A. T. ;
Manchester, Marianne ;
Schneemann, Anette .
PLOS PATHOGENS, 2007, 3 (10) :1422-1431
[25]   Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice [J].
Mason, HS ;
Ball, JM ;
Shi, JJ ;
Jiang, X ;
Estes, MK ;
Arntzen, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (11) :5335-5340
[26]  
Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1
[27]   A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula [J].
Nassal, M ;
Skamel, C ;
Kratz, PA ;
Wallich, R ;
Stehle, T ;
Simon, MM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (02) :655-665
[28]   Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: New particulate Lyme disease vaccines [J].
Nassal, Michael ;
Skamel, Claudia ;
Vogel, Maren ;
Kratz, Peter A. ;
Stehle, Thomas ;
Wallich, Reinhard ;
Simon, Markus M. .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 298 (1-2) :135-142
[29]   X-ray crystallographic structure of the Norwalk virus capsid [J].
Prasad, BVV ;
Hardy, ME ;
Dokland, T ;
Bella, J ;
Rossmann, MG ;
Estes, MK .
SCIENCE, 1999, 286 (5438) :287-290
[30]   Serological Correlate of Protection against Norovirus-Induced Gastroenteritis [J].
Reeck, Amanda ;
Kavanagh, Owen ;
Estes, Mary K. ;
Opekun, Antone R. ;
Gilger, Mark A. ;
Graham, David Y. ;
Atmar, Robert L. .
JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (08) :1212-1218